Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are able to read, understand, and interpret an informed consent form
- People who are willing to sign a written consent form agreeing to take part in an active surveillance programme
- People who are over 50 years of age
- People who have been diagnosed with a single, solid kidney mass smaller than 2 cm, located in one kidney only, and identified for the first time
- People who have no symptoms related to their kidney mass
Who may not be able to join:
- People who have previously been diagnosed with a kidney tumour
- People who have only one functioning kidney
- People whose kidney tumour is linked to an inherited genetic condition, such as tuberous sclerosis or Von Hippel-Lindau syndrome
- People whose cancer has spread to other parts of the body (metastasis)
- People who have a condition that weakens the immune system
- People who are currently taking chemotherapy drugs or medications that suppress the immune system
- People whose life expectancy is estimated to be less than one year
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the therapeutic efficacy of active surveillance for small renal masses; Evaluate the proportion of patients who do not undergone active treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.